{"text": "The results of this meta-analysis suggest that FHIT hypermethylation is associated with an increased risk and worsen survival in NSCLC patients. FHIT hypermethylation, which induces the inactivation of FHIT gene, plays an important role in the carcinogenesis and clinical outcome and may serve as a potential drug target of NSCLC.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 47, "end": 51}}, {"id": "T2", "obj": "disease", "span": {"begin": 129, "end": 143}}, {"id": "T3", "obj": "disease", "span": {"begin": 324, "end": 329}}]}
